IW001 is targeted to idiopathic pulmonary fibrosis (IPF) patients who have autoimmunity against collagen V (40% of all 200,000 IPF patients). IW001 m....
Work for ImmuneWorks? Take ownership of your company’s profile and submit the latest details about your company to keep the investors, strategics, and service providers using our database up-to-date on the work being done at your company.
